Origin of oscillations in molecular mechanism of radioresistance of prostate carcinoma cells: Implications for successful therapy

Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival

Volumn , Issue , 2009, Pages 273-300

  Mitrasinovic, Petar M ^a  

^a Belgrade Institute of Science and Technology   (Serbia)

Author keywords

Antioxidant enzymes; PC 3 cells; Prostate cancer; Radioresistance; Systems biology

Indexed keywords

EID: 84896218361     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Jemal, A., Thomas, A., Murray, T. & Thun, M. (2002). Cancer statistics. CA Cancer J. Clin., 52, 23-47.
2. Lucia, M. S., Darke, A. K., Goodman, P. J., La Rosa, F. G., Parnes, H. L., Ford, L. G., Coltman, C. A., Jr. & Thompson, I. M. (2008). Pathologic characteristics of cancers detected in the prostate cancer prevention trial: implications for prostate cancer detection and chemoprevention. Cancer Prevention Research, 1, 167-173.
3. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. & Thun, M. J. (2008). Cancer statistics. CA Cancer J. Clin., 58, 71-96.
4. Zagars, G. K., Pollack, A. & Smith, L. G. (1999). Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate. Int. J. Radiation Oncology Biol. Phys., 44, 809-819.
5. Kaplan, I. D., Cox, R. S. & Bagshaw, M. A. (1993). Prostate specific antigen after external beam radiotherapy for prostatic cancer: follow-up. J. Urol., 149, 519-522.
6. Mitrasinovic, P. M. (2005). Cross-linking between thymine and indolyl radical: possible mechanisms for cross-linking of DNA and tryptophan-containing peptides. Bioconjugate Chemistry, 6, 588-597.
7. Sansom, C. (2005). Systems biology: will it work? IEE Proceedings of Systems Biology, 2, 1-4.
8. Mesarovic, M. D., Sreenath, S. N. & Keene, J. D. (2004). Search for organizing principles: understanding in systems biology. IEE Proceedings of Systems Biology, 1, 19-27.
9. Sontag, E. D. (2004). Some new directions in control theory inspired by systems biology. IEE Proceedings of Systems Biology, 1, 9-18.
10. Wigle, D. & Jurisica, I. (2007). Cancer as a system failure. Cancer Informatics, 2, 10-18.
11. Kitano, H. (2002). Systems biology: a brief overview. Science, 295, 1662-1664.
12. Sakaki, Y., Kholodenko, B. N., Hatakeyama, M., Kitano, H., Kolch, W., De Meyts, P., Yarden, Y., Westerhoff, H. V. & Wiley, H. S. (2005). International consortium on systems biology of receptor tyrosine kinase regulatory networks. IEE Proceedings of Systems Biology, 152, 53-60.
13. Mitrasinovic, P. M. & Mitrasinovic, O. (2006). On possible mechanisms for reactive oxygen species (ROS)-mediated cross-talk between NF-κB and JNK: a systems biology view. GESTS Int'l Trans. Computer Science and Engr., 27, 41-52.
14. Mitrasinovic, P. M. & Mihajlovic, M. L. (2008). Recent advances in radiation therapy of cancer cells: a step towards an experimental and systems biology framework. Current Radiopharmaceuticals, 1, 22-29.
15. Chen, G. & Goeddel, D. V. (2002). TNF-R1 signaling: a beautiful pathway. Science, 296, 1634-1635.
16. Schweichel J. U. & Merker, H. J. (1973). The morphology of various types of cell death in prenatal tissues. Teratology, 7, 253-266.
17. Fiers, W., Beyaert, R., Declercq, W. & Vandenabeele, P. (1999). More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene, 18, 7719-7730.
18. Kitanaka, C. & Kuchino, Y (1999). Caspase-independent programmed cell death with necrotic morphology. Cell Death. Differ., 6, 508-515.
19. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell, 103, 239-252.
20. Hartwell, L. H., Hopfield, J. J., Leibler, S. & Murray, A. W. (1999). From molecular to modular cell biology. Nature (Supp), 402, C47-C52.
21. Freeman, B. C. & Yamamoto, K. R. (2001). Continuous recycling: a mechanism for modulatory signal transduction. Trends in Biochemical Sciences, 26, 285-290.
22. Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., Torti, F. M., Torti, S. V. & Franzoso, G. (2004). Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell, 119, 529-542.
23. Curtin, J. F., Donovan, M. & Cotter, T. G. (2002). Regulation and measurement of oxidative stress in apoptosis. J. Immunol. Methods, 265, 49-72.
24. Lin, A. (2002). Activation of the JNK signaling pathway: breaking the brake on apoptosis. BioEssays, 25, 17-24.
25. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. & Karin, M. (2005). Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, 649-661.
26. Ihekwaba, A. E. C., Broomhead, D. S., Grimley, R. L., Benson, N. & Kell, D. B. (2004). Sensitivity analysis of parameters controlling oscillatory signaling in the NF-κB pathway: the roles of IKK and IκBα. Systems Biology, 1, 93-103.
27. Kholodenko, B. N. (2000). Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur. J. Biochem., 267, 1583-1588.
28. Hoffmann, A., Levchenko, A., Scott, M. L. & Baltimore, D. (2002). The IκB-NF-κB signaling module: temporal control and selective gene activation. Science, 298, 1241-1245.
29. Neves, S. R. & Iyengar, R (2002). Modeling of signaling networks. BioEssays, 24, 1110-1117.
30. Mendes, P. & Kell, D. (1998). Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics, 14, 869-883.
31. Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular single-regulated kinase activation. Cell, 80, 179-185.
32. Covert, M. W., Leung, T. H., Gaston, J. E. & Baltimore, D. (2005). Achieving stability of lipopolysaccharide-induced NF-κB activation. Science, 309, 1854-1857.
33. Werner, S. L., Barken, D. & Hoffmann, A. (2005). Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science, 309, 1857-1861.
34. Ferrel, J. E., Jr & Machleder, E. M. (1998). The biochemical basis of an all-or-none cell fate switch in Xenopus Oocytes. Science, 280, 895-898.
35. Shukla, S., MacLennan, G. T., Fu, P., Patel, J., Marengo, S. R., Resnick, M. I., & Gupta, S. (2004). Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia, 6, 390-400.
36. Lin, A. & Karin, M. (2003). NF-kappaB in cancer: a marked target. Semin. Cancer. Biol., 13, 107-114.
37. Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W. & Aggarwal, B. B. (1998). Overexpression of manganese superoxide dismutase suppresses tumor necrosis factorinduced apoptosis and activation of nuclear transcription factor-B and activated protein-1. J. Biol. Chem., 273, 13245-13254.
38. Kim, H. T., Kim, Y. H., Nam, J. W., Lee, H. J., Rho, H. M. & Jung, G. (1994). Study of 5'-flanking region of human Cu/Zn superoxide dismutase. Biochem. Biophys. Res. Commun., 201, 1526-1533.
39. Xu, Y., Kiningham, K. K., Devalaraja, M. N., Yeh, C. C., Majima, H., Kasarskis, E. J. & St Clair, D. K. (1999). An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol., 18, 709-722.
40. Zhou, L. Z., Johnson, A. P. & Rando, T. A. (2001). NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med., 31, 1405-1416.
41. Jung, K., Seidel, B., Rudolph, B., Lein, M., Cronauer, M. V., Henke, W., Hampel, G., Schnorr, D. & Loening, S. A. (1997). Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med., 23, 127-133.
42. Oberley, T. D., Zhong, W., Szweda, L. I. & Oberley, L. W. (2000). Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate, 44, 144-155.
43. Gajewska, J., Szczypka, M., Izbicki, T., Klepacka, T. & Laskowska-Klita, T. (1996). Antioxidant and glutathione-associated enzymes in Wilms' tumor after chemotherapy. J. Cancer Res. Clin. Oncol., 122, 483-488.
44. Chen, Q. M., Liu, J. & Merrett, J. B. (2000). Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human. Biochem. J., 347, 543-551.
45. Niciforovic, A., Djordjevic, J., Adzic, M., Vucic, V., Mitrasinovic, P. M. & Radojcic, M. B. (2008). Experimental and systems biology studies of the molecular basis for the radioresistance of prostate carcinoma cells. Annals of Biomedical Engineering, 36, 831-838.
46. Mitrasinovic, P. M. (2006). Systems biology studies of reactive oxygen species (ROS)-mediated apoptosis. Proceedings of the 8th International Conference on Fundamental and Applied Aspects of Physical Chemistry, 1, 279-281.
47. Isaacs, W. B., Carter, B. S. & Ewing, C. M. (1991). Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51, 4716-4720.
48. Raffoul, J. J., Wang, Y., Kucuk, O., Forman, J. D., Sarkar, F. H. & Hillman, G. G. (2006). Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer, 6, 107.
49. Vucic, V., Isenovic, E. R., Adzic, M., Ruzdijic, S. & Radojcic, M. B. (2006). Effects of gamma-radiation on cell growth, cycle arrest, death, and superoxide dismutase expression by DU 145 human prostate cancer cells. Braz. J. Med. Biol. Res., 39, 227-236.
50. Joiner, M. C., Marples, B., Forman, J. D. & Sarkar, F. H. (2004). Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther., 3, 1271-1279.
51. Pawlik, T. M. & Keyomarsi, K. (2004). Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys, 59, 928-942.
52. Sweeney, C., Li, L., Shanmugam, R., Bhat-Nakshatri, P., Jayaprakasan, V., Baldridge, L. A., Gardner, T., Smith, M., Nakshatri, H. & Cheng, L. (2004). Nuclear factorkappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin. Cancer Res., 10, 5501-5507.
53. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W. & Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 282, 1497-150.
54. Lim, S. D., Sun, C., Lambeth, J. D., Marshall, F., Amin, M., Chung, L., Petros, J. A. & Arnold, R. S. (2005). Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate, 62, 200-207.
55. Roninson, I. B. (2002). Tumor senescence as a determinant of drug response in vivo. Drug Resist. Updat., 5, 204-208.
56. Barnouin, K., Dubuisson, M. L., Child, E. S., Fernandez de Mattos, S., Glassford, J, Medema, R. H., Mann, D. J. & Lam, E. W. (2002). H2O2 induces a transient multiphase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J Biol Chem., 277, 13761-13770.
57. Li, S., Yan, T., Yang, J. Q., Oberley, T. D. & Oberley, L. W. (2000). The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res., 60, 3927-3939.
58. Rhee, S., Bae, Y., Lee, S. R. & Kwon, J. (2000). Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE., 53, PE1.
59. Bernard, D., Monte, D., Vandenbunder, B. & Abbadie, C. (2002). The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene, 21, 4392-4402.
60. Wang, C. Y., Mayo, M. W. & Baldwin, A. S., Jr (1996). TNF- and cancer therapyinduced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784-787.
61. Buettner, G. R., Ng. F., Chin, M., Wang, V., Rodgers, G. J. & Schafer, F. Q. (2006). A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med., 41, 1338-1350.
62. Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W. & Aggarwal, B. B. (1998). Overexpression of manganese superoxide dismutase suppresses tumor necrosis factorinduced apoptosis and activation of nuclear transcription factor-B and activated protein-1. J. Biol. Chem., 273, 13245-13254.
63. Pajonk, F., Pajonk, K. & McBride, W. H. (1999). Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells. J. Natl. Cancer Inst., 91, 1956-1960.
64. Fersht, A. (1985). Enzyme structure and mechanism. NewYork, NY: W. H. Freeman and Company, p. 475.
65. Vilenchik, M. M. & Knudson, A. G., Jr. (2000). Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage. Proc. Natl Acad. Sci. USA, 97, 5381-5386.
66. Shi, X., Dong, Z., Huang, C., Ma, W., Liu, K., Ye, J., Chen, F., Leonard, S. S., Ding, M., Castranova, V. & Vallyathan, V. (1999). The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB. Mol. Cell Biochem., 194, 63-70.
67. Guo, G., Yan-Sanders, Y., Lyn-Cook, B. D., Wang, T., Tamae, D., Ogi, J., Khaletskiy, A. Li. Z., Weydert, C., Longmate, J. A., Huang, T. T., Spitz, D. R., Oberley, L. W. & Li, J. J. (2003). Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol. Cell Biol., 23, 2362-2378.
68. Huang, T. T., Yasunami, M., Carlson, E. J., Gillespie, A. M., Reaume, A. G., Hoffman, E. K., Chan, P. H., Scott, R. W. & Epstein, C. J. (1997). Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys., 344, 424-432.